Aktiesnakken — Marts 2010
-
hvem fra hvad!?
-
ham der stillede spørgsmålet
-
gsks commitment?
-
ja - omkring arzerra udvikling
-
ush - lisa er sur og aldeles bitchy i dag.
-
kan jeg da godt forstå, hvis de kun skal betale 12,8 million til genmab:)
-
van der vinkel han er min type
-
winkel siger groft sagt at gsk er mere engageret nu end for et år siden....
-
han er en raiser
-
det er lidt en gratis omgang, han tog der winkel
-
så slutter vi af - der var ikke mget nyt der
-
hvor blev farlig frank af?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind